Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis.
Method for the systematic reviews on occupational therapy and neurodegenerative diseases.
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients.
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
2015 Multiple Sclerosis Experts Summit.
Analysis of the direct injury effector of oligodendroglia cells or myelin sheath in an experimental allergic encephalomyelitis model induced by the MOG35-55 peptide.
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Metabolic Control of Th17 Cell Generation and CNS Inflammation.
Italian validation of the 12-item multiple sclerosis walking scale.
The fatigue-motor performance paradox in multiple sclerosis.
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
High rates of physician services utilization at least five years before multiple sclerosis diagnosis.
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Evidence for classic complement activity in neuromyelitis optica.
LOGISMOS-B: Layered Optimal Graph Image Segmentation of Multiple Objects and Surfaces for the Brain.
Update on neurodegeneration with brain iron accumulation.
Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »